| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26863e18d6c8e79c46b17e46d6e2d83a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9b180619dda9207d51b96a9cc78a0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d077b7451d4d0e2ade4b4063146e78d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24abae1e0c184374c5a63f6319b4a759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6fa7731688273d3b3810e17f75655c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fb339c774791aec962066b2097beaa8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6869 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2010-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78391453ee56f5d8189dfd66be76db23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa3c73d78a7b8531385a1a170e181b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_318e38d61f73ff60fae08b3d3afc4e38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f33d2de69030d86d83d4f55a74455ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_846d88e1bf915e32ea287d033c5d8607 |
| publicationDate |
2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8629247-B2 |
| titleOfInvention |
Antibodies against prostate specific membrane antigen |
| abstract |
Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic purposes are provided herein. Formulation anti-PSMA antibodies which are stable under extreme storage condition are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782478-B1 |
| priorityDate |
2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |